Tandem Diabetes Care Inc reports results for the quarter ended in September 30 - Earnings Summary

• Tandem Diabetes Care Inc TNDM.OQ reported a quarterly adjusted loss of 35 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -38 cents. The mean expectation of twenty analysts for the quarter was for a loss of 41 cents per share. Wall Street expected results to range from -50 cents to -27 cents per share.

• Revenue rose 31.4% to $243.97 million from a year ago; analysts expected $223.66 million.

• Tandem Diabetes Care Inc's reported EPS for the quarter was a loss of 35 cents​.

• The company reported a quarterly loss of $23.25 million.

• Tandem Diabetes Care Inc shares had fallen by 21.9% this quarter and gained 11.9% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 2.1% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy," 6 "hold" and 1 "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Tandem Diabetes Care Inc is $56.50

This summary was machine generated from LSEG data November 7 at 04:41 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)